Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts

Aging Clinical and Experimental Research

Volumn 28, Issue 2, 2016, Pages 181-187

  Xie, Cuihong ^a   Shen, Yingnian ^a   Hu, Weilin ^a   Chen, Zhengping ^a   Li, Yongsheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiotensin II; Myofibroblast; Valvular calcification; Wnt Catenin

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; VALSARTAN; WNT3A PROTEIN; ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ANIMAL CELL; AORTA VALVE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; MYOFIBROBLAST; NONHUMAN; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; AORTIC VALVE; CALCINOSIS; CELL TRANSDIFFERENTIATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PIG;

ACTINS; ALKALINE PHOSPHATASE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTIC VALVE; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; MYOFIBROBLASTS; OSTEOBLASTS; PHENOTYPE; SWINE; VALSARTAN; WNT SIGNALING PATHWAY;

EID: 84961200410     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-015-0408-2     Document Type: Article

References (31)

1. Dichtl W, Alber HF, Feuchtner GM et al (2008) Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). Am J Cardiol 102(6):743–748
2. Kennedy JA, Hua X, Mishra K et al (2009) Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors. Eur J Pharmacol 602(1):28–35
3. Price PA, Buckley JR, Williamson MK (2001) The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 131(11):2910–2915
4. Liu AC, Joag VR, Gotlieb AI (2007) The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 171(5):1407–1418
5. Liu AC, Gotlieb AL (2007) Characterization of cell motility in single heart valve interstitial cells in vitro. Histol Histopathol 22:873–882
6. Taylor PM, Batten P, Brand NJ et al (2003) The cardiac valve interstitial cell. Int J Biochem Cell Biol 35(2):113–118
7. O’Brien KD, Shavelle DM, Caulfield MT et al (2002) Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106:2224–2230
8. Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011
9. Xin D (2005) The diagnostic value of color Doppler echocardiography in the degenerative valvular heart disease. Chin J Ultrasound Diagnosis 6(3):212–213[Chinese]
10. Rajamannan NM, Subramaniam M, Caira F et al (2005) Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112(I):229–234
11. Yip CY, Chen JH, Zhao R et al (2009) Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 29:936–942
12. Desmouliere A (1995) Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 19:471–476
13. Merryman WD, Lukoff HD, Long RA et al (2007) Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol 16(5):268–276
14. Kaden JJ, Kiliç R, Sarikoç A et al (2005) Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int J Mol Med 16(5):869–872
15. Kaden JJ, Dempfle CE, Kiliç R et al (2005) Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts. Exp Mol Pathol 78(1):36–40
16. Steinmetz M, Skowasch D, Wernert N et al (2008) Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves. J Heart Valve Dis 17:187–193
17. Rajamannan NM, Subramaniam M, Rickard D et al (2003) Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107(17):2181–2184
18. Nadir MA, Wei L, Elder DH et al (2011) Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol 58(6):570–576
19. Yamamoto K, Yamamoto H, Yoshida K et al (2010) Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis. Hypertens Res 33(3):269–274
20. Ngo DT, Sverdlov AL, Mc Neil JJ et al (2009) Correlates of arterial stiffness in an ageing population: role of asymmetric dimethylarginine. Pharmacol Res 60:503–507
21. Fujisaka T, Hoshiga M, Hotchi J et al (2013) Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice. Atherosclerosis 226:82–87
22. Osako MK, Nakagami H, Koibuchi N et al (2010) Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res 107:466–475
23. Kaneko K, Ito M, Fumoto T et al (2011) Physiological function of the angiotensin AT1a receptor in bone remodeling. J Bone Miner Res 26(12):2959–2966
24. Ngo DT, Stafford I, Sverdlov AL et al (2011) Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. Br J Pharmacol 162:722–732
25. Volzke H, Haring R, Lorbeer R et al (2010) Heart valve sclerosis predicts all-cause and cardiovascular mortality. Atherosclerosis 209:606–610
26. Otto CM, O’Brien KD (2001) Why is there discordance between calcific aortic valve stenosis and coronary artery disease? Heart 85:601–602
27. Arishiro K, Hoshiga M, Negoro N et al (2007) Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. J Am Coll Cardiol 49:1482–1489
28. Clevers H (2006) Wnt/β-Catenin signaling in development and disease. Cell 127(3):469–480
29. Faverman L, Mikhaylova L, Malmquist J et al (2008) Extracellular transglutaminase 2 activates b-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 582(10):1552–1557
30. Roy A, Brand NJ, Yacoub MH (2000) Molecular characterization of interstitial cells isolated from human heart valves. J Heart Valve Dis 9:459–645
31. Caira FC, Stock SR, Gleason TG et al (2006) Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 47:1707–1712